14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of SAGE
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Strong day for Sage Therapeutics stock price on Friday rising 6.37% to $13.94
(Updated on May 03, 2024)

Hold candidate since May 03, 2024 PDF

The Sage Therapeutics stock price gained 6.37% on the last trading day (Friday, 3rd May 2024), rising from $13.11 to $13.94. During the last trading day the stock fluctuated 3.87% from a day low at $13.45 to a day high of $13.97. The price has been going up and down for this period, and there has been a 4.58% gain for the last 2 weeks. Volume fell on the last day by -40 thousand shares and in total, 875 thousand shares were bought and sold for approximately $12.19 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $14.58 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -46.33% during the next 3 months and, with a 90% probability hold a price between $5.44 and $7.83 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

SAGE Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, April 17, 2024, and so far it has risen 10.90%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Sage Therapeutics stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $16.14. On a fall, the stock will find some support from the short-term average at $13.67. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for Sage Therapeutics stock

Sage Therapeutics finds support from accumulated volume at $13.28 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.520 between high and low, or 3.87%. For the last week, the stock has had daily average volatility of 5.93%.

Our recommended stop-loss: $13.39 (-3.92%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 12 days ago.)

Trading Expectations (SAGE) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Sage Therapeutics to open at $13.79, and during the day (based on 14 day Average True Range), to move between $12.94 and $14.94, which gives a possible trading interval of +/-$1.00 (+/-7.15%) up or down from last closing price. If Sage Therapeutics takes out the full calculated possible swing range there will be an estimated 14.30% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $14.00 (0.43%) than the support at $13.28 (4.73%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Sage Therapeutics stock A Buy?

Sage Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: -0.917 Hold/Accumulate Upgraded

Predicted Opening Price for Sage Therapeutics of Monday, May 6, 2024

Fair opening price May 6, 2024 Current price
$13.79 ( 1.10%) $13.94

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for SAGE

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 14.31 2.63 %
R2 14.11 1.21 %
R1 13.99 0.325 %
Current price: 13.94
Support S1 13.59 -2.52 %
S2 13.47 -3.41 %
S3 13.27 -4.83 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 15.63 12.12 %
R2 15.44 10.76 %
R1 14.00 0.430 %
Current price 13.94
Support S1 13.28 -4.73%
S2 13.04 -6.49%
S3 12.57 -9.83%

FAQ

What is the symbol for Sage Therapeutics Stock and on which exchange is it traded?
The symbol for Sage Therapeutics is SAGE and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Sage Therapeutics Stock?
Sage Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy Sage Therapeutics Stock?
Sage Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Sage Therapeutics Stock.

What's the current price of Sage Therapeutics Stock?
As of the end of day on the May 03, 2024, the price of an Sage Therapeutics (SAGE) share was $13.94.

What is the 52-week high and low for Sage Therapeutics Stock?
The 52-week high for Sage Therapeutics Stock is $59.98 and the 52-week low is $10.92.

What is the market capitalization of Sage Therapeutics Stock?
As of the May 03, 2024, the market capitalization of Sage Therapeutics is 788.685M.

When is the next earnings date for Sage Therapeutics?
The upcoming earnings date for Sage Therapeutics is Aug 05, 2024.
Click to get the best stock tips daily for free!

About Sage Therapeutics

Sage Therapeutics Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive steroid, which is in Phase III clinical trials for treating PPD, major depressive disorders, treatment... SAGE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT